AGP Executive Report
Last update: 2 hours agoTrade & Tariffs: Trump’s Sept. 29 ban on Canadian alcohol, dairy and motorcycles is set to hit a major export market, with industry warning of a “tornado of changes” for distillers and manufacturers. Public Health: Ontario adds CAPVAXIVE to its publicly funded adult pneumococcal immunization program, while a new review finds PPV23 doesn’t clearly cut cardiovascular risk. Health & Medicine: FDA cleared Boston Scientific’s SpaceOAR Flex hydrogel spacer for prostate radiotherapy, and AbbVie posted positive phase 3 results for atogepant in menstrual migraine prevention. Competition Watch: Canada’s Competition Bureau says grocery minimum advertised pricing rules can block stores from advertising the lowest deals. Energy & Environment: A new Australian tool is being used to estimate real-world climate impacts of fossil-fuel projects, including Canada’s Bay du Nord. Workplace Safety: A report says Alberta’s COVID-19 response at the Cargill meat plant was a “catastrophic failure,” driven by regulatory shortcomings. Business & Jobs: Stelco idles its Hamilton plant and shifts production to Lake Erie, while MedLegalPsych launches independent psychiatric IME services in Winnipeg.
Note: AI summary from news headlines; neutral sources weighted more to help reduce bias in the result. Feedback is welcome. Please let us know if you have any comments or suggestions about the AGP Executive Report.
Perspectify News
